Béatrice Desvergne Selected Research

Béatrice Desvergne Research Topics

Disease

11	Inflammation (Inflammations) 01/2019 - 02/2004
8	Obesity 12/2012 - 04/2002
5	Wounds and Injuries (Trauma) 05/2005 - 10/2002
4	Type 2 Diabetes Mellitus (MODY) 01/2017 - 11/2002
4	Insulin Resistance 06/2008 - 11/2002
4	Metabolic Syndrome (Dysmetabolic Syndrome X) 04/2006 - 04/2002
3	Neoplasms (Cancer) 05/2007 - 06/2002
3	Metabolic Diseases (Metabolic Disease) 08/2006 - 08/2005
2	Lipodystrophy 01/2018 - 12/2012
2	Pulmonary Hypertension 03/2010 - 02/2006
2	Ischemia 05/2007 - 08/2005
2	Hypoglycemia (Reactive Hypoglycemia) 09/2006 - 01/2005
2	Body Weight (Weight, Body) 10/2004 - 04/2002
1	Chronic Disease (Chronic Diseases) 11/2021
1	Osteoporosis 01/2021
1	Hyperphagia (Overeating) 01/2019
1	Diabetic Nephropathies (Diabetic Nephropathy) 01/2018
1	Hyperglycemia 01/2018
1	Renal Insufficiency (Renal Failure) 01/2017
1	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 01/2017
1	Carcinogenesis 01/2015
1	Postmenopausal Osteoporosis 05/2013
1	Infections 01/2012
1	Sepsis (Septicemia) 12/2010
1	Endotoxemia 12/2010
1	Septic Shock (Toxic Shock Syndrome) 12/2010
1	Shock 12/2010
1	Pneumonia (Pneumonitis) 12/2010
1	Pulmonary Arterial Hypertension 03/2010
1	Hypoxia (Hypoxemia) 03/2010
1	Cardiomegaly (Heart Hypertrophy) 03/2010
1	Nervous System Diseases (Neurological Disorders) 01/2008
1	Leukemia 12/2007
1	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 05/2007
1	Nevus (Nevi) 05/2007
1	Ischemic Stroke 05/2007
1	Melanoma (Melanoma, Malignant) 05/2007
1	Brain Ischemia (Cerebral Ischemia) 05/2007
1	Papilloma (Papillomatosis) 05/2007
1	Stroke (Strokes) 05/2007
1	Dyslipidemias (Dyslipidemia) 02/2006
1	Acute Kidney Injury (Acute Renal Failure) 08/2005
1	Necrosis 08/2005
1	Kidney Calculi (Kidney Stone) 06/2005
1	Primary hyperoxaluria type 2 06/2005
1	Colitis 04/2005
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 04/2005
1	Starvation 01/2005

Drug/Important Bio-Agent (IBA)

15	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2018 - 06/2002
14	PPAR-betaIBA 03/2010 - 10/2002
10	PPAR gammaIBA 05/2010 - 11/2002
7	Glucose (Dextrose)FDA LinkGeneric 01/2019 - 04/2002
5	LipidsIBA 01/2019 - 04/2002
5	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 01/2015 - 04/2005
5	PPAR alphaIBA 02/2010 - 05/2004
4	LigandsIBA 02/2006 - 11/2002
3	Transcription Factors (Transcription Factor)IBA 01/2015 - 04/2006
3	Fatty Acids (Saturated Fatty Acids)IBA 02/2010 - 01/2005
2	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2018 - 05/2005
2	CreatinineIBA 01/2017 - 08/2005
2	(4- (((2- (3- fluoro- 4- (trifluoromethyl)phenyl)- 4- methyl- 1,3- thiazol- 5- yl)methyl)sulfanyl)- 2- methylphenoxy)acetic acidIBA 12/2010 - 03/2010
2	Epoprostenol (Prostacyclin)FDA LinkGeneric 03/2010 - 02/2006
2	PPAR deltaIBA 06/2008 - 12/2007
2	Pharmaceutical PreparationsIBA 08/2006 - 04/2005
2	CholesterolIBA 08/2005 - 04/2002
2	Insulin (Novolin)FDA Link 11/2002 - 04/2002
1	AdipoRonIBA 01/2021
1	Amino Acids FDA Link 01/2019
1	AntibodiesIBA 01/2017
1	Immunoglobulin G (IgG)IBA 01/2017
1	Immunoglobulin M (IgM)IBA 01/2017
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2013
1	lipineIBA 12/2012
1	vasostatinIBA 01/2012
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 12/2010
1	Glycogen Synthase KinasesIBA 12/2010
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 12/2010
1	Endothelin Receptor AntagonistsIBA 03/2010
1	Phosphodiesterase 5 InhibitorsIBA 03/2010
1	Diethylhexyl Phthalate (DEHP)IBA 02/2010
1	mono-(2-ethylhexyl)phthalateIBA 05/2009
1	AntioxidantsIBA 01/2008
1	Neuroprotective AgentsIBA 01/2008
1	Retinoid X Receptor alphaIBA 05/2007
1	Calcitriol Receptors (Calcitriol Receptor)IBA 05/2007
1	treprostinil FDA Link 02/2006
1	4- (3- (2- propyl- 3- hydroxy- 4- acetyl)phenoxy)propyloxyphenoxy acetic acidIBA 08/2005
1	OxalatesIBA 06/2005
1	glyoxylate reductaseIBA 06/2005
1	Hydroxypyruvate ReductaseIBA 06/2005
1	EnzymesIBA 06/2005
1	Transforming Growth Factor beta1 (TGF beta 1)IBA 05/2005
1	Transforming Growth Factor beta (TGF-beta)IBA 05/2005
1	Chemotactic FactorsIBA 05/2005
1	Mesalamine (Mesalazine)FDA LinkGeneric 04/2005
1	Biological ProductsIBA 11/2004

Therapy/Procedure

2	Therapeutics 03/2010 - 04/2002
1	Precision Medicine 11/2021
1	Punctures 12/2010
1	Ligation 12/2010